Possible DSIP Side Effects and Safety Concerns Because modern human safety data is limited, the full risk profile of DSIP is not well established
VV is serving as one of the Guest editors of this journal
Quick Answer GHK-Cu peptide therapy may be considered by adults seeking support for skin appearance, hair health, recovery or healthy-aging goals
Yamamoto et al., 2020)
Back to Journals Neuropsychiatric Disease and Treatment Volume 22 Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis Authors Kumar R , Hashempour Z, Shahriarirad S, Shahriarirad R, Hassett LC, Singh B , Croarkin PE , Veldic M, Frye MA, Pagali SR Received 6 January 2026 Accepted for publication 12 March 2026 Published 3 June 2026 Volume 2026:22 586506 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Roger Pinder Rakesh Kumar, 1 Zahra Hashempour, 2 Sara Shahriarirad, 2 Reza Shahriarirad, 3 Leslie C Hassett, 4 Balwinder Singh, 1 Paul E Croarkin, 1 Marin Veldic, 1 Mark A Frye, 1 Sandeep R Pagali 5 1 Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA
Shukurova, S., Sadek, R., Mekawy, N., Bendaoud, M., Yachou, Y., Mamchyn, A., & El Idrissi, A
